David Efraim Rosen, 10% Owner at TherapeuticsMD, Inc. (TXMD), bought 129,784 shares at $5.56 ($722K) on 2022-07-15, disclosed to the SEC on 2022-07-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.56 | 64,892 | $361K | 50.0% |
| 2 | $5.56 | 64,892 | $361K | 50.0% |
| Total | $5.56 avg | 129,784 | $722K | 100% |
| Filing → |
| TXMD | BUY | 2022-12-09 | $229K | — | Filing → |
| TXMD | BUY | 2022-08-01 | $2.7M | — | Filing → |
| RDUS | BUY | 2021-12-15 | $6.4M | — | Filing → |